- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x 7O9: (2~{S},3~{S})-2-azanyl-3-[[3-[[4-(trifluoromethyl)phenyl]carbonylamino]phenyl]methoxy]butanedioic acid(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.2: 8 residues within 4Å:- Chain A: K.89, V.92, R.93, V.96, Y.97, L.303, V.308, L.465
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:V.92, A:V.96, A:L.303, A:V.308, A:L.465
- Salt bridges: A:K.89, A:R.93
Y01.10: 8 residues within 4Å:- Chain B: K.89, V.92, R.93, V.96, Y.97, L.303, V.308, L.465
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:V.92, B:V.96, B:L.303, B:V.308, B:L.465
- Salt bridges: B:K.89, B:R.93
Y01.17: 8 residues within 4Å:- Chain C: K.89, V.92, R.93, V.96, Y.97, L.303, V.308, L.465
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:V.92, C:V.96, C:L.303, C:V.308, C:L.465
- Salt bridges: C:K.89, C:R.93
- 15 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PC1.3: 14 residues within 4Å:- Chain A: V.79, L.82, D.83, V.86, S.87, V.95, V.96, F.99, L.224, K.228, T.402, S.403, I.406
- Ligands: PC1.4
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:V.79, A:L.82, A:V.95, A:V.96, A:F.99, A:L.224
- Salt bridges: A:K.228
PC1.4: 3 residues within 4Å:- Chain A: L.224, K.228
- Ligands: PC1.3
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.224
- Salt bridges: A:K.228
PC1.5: 3 residues within 4Å:- Chain A: M.149, K.228
- Ligands: PC1.8
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:K.228
PC1.6: 5 residues within 4Å:- Chain A: L.103, I.107, V.114, I.394, S.398
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.103, A:I.107, A:I.394
PC1.7: 8 residues within 4Å:- Chain A: W.19, M.62, L.65, I.253, C.256, Y.257
- Chain C: F.218
- Ligands: PC1.20
4 PLIP interactions:1 interactions with chain C, 3 interactions with chain A- Hydrophobic interactions: C:F.218, A:L.65, A:I.253, A:Y.257
PC1.8: 7 residues within 4Å:- Chain A: F.218
- Chain B: W.19, M.62, L.65, I.253, C.256
- Ligands: PC1.5
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:W.19, B:L.65, A:F.218
PC1.11: 14 residues within 4Å:- Chain B: V.79, L.82, D.83, V.86, S.87, V.95, V.96, F.99, L.224, K.228, T.402, S.403, I.406
- Ligands: PC1.12
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:V.79, B:L.82, B:V.95, B:V.96, B:F.99, B:L.224
- Salt bridges: B:K.228
PC1.12: 3 residues within 4Å:- Chain B: L.224, K.228
- Ligands: PC1.11
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.224
- Salt bridges: B:K.228
PC1.13: 4 residues within 4Å:- Chain B: M.149, K.228
- Chain C: I.253
- Ligands: PC1.15
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:K.228, C:I.253
PC1.14: 5 residues within 4Å:- Chain B: L.103, I.107, V.114, I.394, S.398
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:L.103, B:I.107, B:I.394
PC1.15: 7 residues within 4Å:- Chain B: F.218
- Chain C: W.19, M.62, L.65, I.253, C.256
- Ligands: PC1.13
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:F.218, C:L.65, C:I.253
PC1.18: 14 residues within 4Å:- Chain C: V.79, L.82, D.83, V.86, S.87, V.95, V.96, F.99, L.224, K.228, T.402, S.403, I.406
- Ligands: PC1.19
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:V.79, C:L.82, C:V.95, C:V.96, C:F.99, C:L.224
- Salt bridges: C:K.228
PC1.19: 3 residues within 4Å:- Chain C: L.224, K.228
- Ligands: PC1.18
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.224
- Salt bridges: C:K.228
PC1.20: 4 residues within 4Å:- Chain A: I.253
- Chain C: M.149, K.228
- Ligands: PC1.7
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: C:K.228, A:I.253
PC1.21: 5 residues within 4Å:- Chain C: L.103, I.107, V.114, I.394, S.398
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:L.103, C:I.107, C:I.394
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baronina, A. et al., Structure of human excitatory amino acid transporter 3 (EAAT3). TO BE PUBLISHED
- Release Date
- 2020-07-08
- Peptides
- Excitatory amino acid transporter 3: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x 7O9: (2~{S},3~{S})-2-azanyl-3-[[3-[[4-(trifluoromethyl)phenyl]carbonylamino]phenyl]methoxy]butanedioic acid(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 15 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baronina, A. et al., Structure of human excitatory amino acid transporter 3 (EAAT3). TO BE PUBLISHED
- Release Date
- 2020-07-08
- Peptides
- Excitatory amino acid transporter 3: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.